Nancy J Kelley, JD, MPP
Nancy J Kelley is currently the President & CEO of Nancy J Kelley + Associates.
Nancy J Kelley + Associates build things that matter for science and medicine in order to solve some of the world’s most intractable problems. We are committed to delivering scientific and medical breakthroughs, whether by advancing translational genomic research that has the potential to cure human disease and improve quality of life, or facilitating ways that we can feed, fuel and heal the world through technological innovation in biology.
The firm focuses in five major areas:
- Creation of Game Changing Projects/Institutions,
- Design, development and construction of Life Science Environments,
- Evaluation of Cutting Edge Technologies,
- Ground Breaking Research, and
- Community Engagement through major meetings and workshops.
Nancy J Kelley is a senior executive and lawyer with exceptional leadership ability and management skills. She has over twenty years of executive management and board experience in starting, growing, and restructuring organizations, raising capital, recruiting diverse management teams, creating and implementing strategic plans, developing real estate, developing internet based information platforms, data warehouses and marketing/branding. She has a particularly deep understanding of the healthcare, life science and research fields and has in-depth knowledge of the related legal, business, government, non-profit and academic sectors.
Ms Kelley served as the Founding Executive Director of the New York Genome Center. From its establishment in 2010 by its 11 Institutional Founding Members, she led the Center from a start up to a fully operational, world class genomics research center and provider of cutting edge sequencing and bioinformatics services, raising $110 million to do so. Many of NYGC’s foundational elements, such as its Pilot Laboratory at Rockefeller University, the NYGC Innovation Center, and key clinical and technology partnerships, were established under her leadership. Ms. Kelley oversaw the selection and build out of NYGC’s permanent facility at 101 Avenue of the Americas in New York City, which opened in September, 2013. She also recruited a large scientific and management team as well as several of the Center’s Associate Members.
New York Genome Center
East River Science Park, Manhattan
Before her time at NYGC, she was a Senior Vice President of Business Development and Strategic Operations Alexandria Real Estate Equities (ARE), where she was a leader on the East River Science Park project, a commercial translational research development in Manhattan, which encompasses over 1 million square feet of life science space. It currently houses a continuum of life science users from early stage companies to public health organizations, academic medical centers and large pharmaceuticals, as well as scientific support services.
Ms. Kelley concluded a strategic partnership for ARE, on the science side, with Nature Publishing Group, one of the most prestigious scientific publishing organizations in the world. Together they launched Nature Network Boston, a network intended to facilitate communication and research among scientists. Ms. Kelley also successfully launched ARE at BIO 2005, the largest biopharma conference in the world, which was followed by a larger presence at BIO 2006.
Prior to her employment at ARE, Ms. Kelley was Senior Vice President and Managing Director of Life Sciences, worldwide, for Spaulding & Slye Colliers and Colliers International (“Colliers”) where clients included, amongst others, the National Institutes of Health, Johns Hopkins University, the Massachusetts Institute of Technology; Boston University/Boston Medical Center; and Novartis, Pfizer, Genzyme and Perkin Elmer. At the time of Ms. Kelley’s departure, the Colliers Life Sciences Group consisted of more than 110 professionals specializing in structured finance and investment sales, development services, construction, leasing and facility management. The Life Sciences Group had 6 million square feet of life science space under development and managed over 3.5 million square feet of life science facility space.
In 2004, Ms. Kelley was the principal author/editor of Alchemy, a first-of-its-kind Global Life Sciences Real Estate Report intended to help decision-makers from biotechnology and pharmaceutical companies, together with research and health care institutions, speed scientific advances from bench to bedside and beyond. She is also the principal author/editor of Elements, 2007, a follow-on publication that was released by Colliers at BIO 2007. Ms. Kelley has written and spoken extensively on these topics.
Ms. Kelley on the cover of BioIT World
Ms. Kelley gained real estate master planning experience in the life sciences arena when she chaired a task force on behalf of the Town of Belmont, Massachusetts that managed the master planning, negotiation and redevelopment of 240 acres of land in Belmont owned by McLean Hospital, Partners Healthcare, and Massachusetts General Hospital. During this three-year process, the McLean Hospital Task Force negotiated an agreement with McLean Hospital that rezoned the property from residential to commercial use and resulted in benefits for the Town of Belmont totaling over $75 million. The Agreement was endorsed by major news editorial Boards, approved overwhelmingly by Town committees and passed by a two-thirds referendum in the Town of Belmont.
Nancy J. Kelley giving the award to the best academic scientists of the year.
As an advisor and founder of growth companies, Ms. Kelley acquired years of experience in growing life science companies from start-up through development into established enterprises. As a former corporate securities junior partner at the Boston law firm of Hale and Dorr (now Wilmer Hale) her practice focused on a range of corporate and securities matters for leading private and publicly traded high technology companies and investment banks in the biotechnology, medical instrumentation, and health care industries. Her specific expertise included: the private placement and public offering of securities, mergers and acquisitions, venture capital investment, research and development agreements, joint ventures, strategic alliances, technology transfer and intellectual property protection.
In addition to her private sector experience, Ms. Kelley has a broad background in the nonprofit, public, and academic sectors.
In 1988-1989, Ms. Kelley was appointed a White House Fellow and served as a Special Assistant to the U.S. Trade Representative in the Executive Office of the President. While studying at Harvard University, she co-founded and led a research and teaching project at the John F. Kennedy School of Government’s Center for Business and Government entitled, “The Community Revitalization Project.” She also founded and taught the first clinical course on social entrepreneurship at Harvard Law School, after having participated in the founding of City Year and other social ventures. In 1982, she was appointed a Truman Scholar from Connecticut.
Ms. Kelley currently serves or has served on Boards for The New York Genome Center, The Jackson Laboratory, Beth Israel Deaconess Medical Center, and the Whitehead Institute, amongst others.
See Nancy’s Wall Street Journal Profile.
Ms. Kelley speaking at US Healthcare & Life Sciences Conference, 2012
Representative Projects Over the Last Several Years Include:
Created and launched an advanced diagnostic testing company on behalf of Roswell Park Cancer Institute. Conducted technology and market assessments, developed comprehensive business plan and financial model. Led (re)negotiation of business and technical relationships. Created plan for initial operations and led implementation of time-critical components, as well as legal analysis for spin-out of the business. Received $25 million in funding for the project. View website
Co-sponsored series of scientific meetings with the Alfred P Sloan Foundation, Woodrow Wilson International Center for Scholars, NYU Langone Medical Center and the National Science Foundation SAVI, which ultimately resulted in the publication of a commentary in Science with 25 authors, the creation of a new Center of Excellence for Engineering Biology and the establishment of a Grand Challenge project for Engineering Biology called GP/HGP-write
Precision Medicine/ Wellness
Developed a strategic assessment and organizational/financial overview for a new Precision Wellness Research Institute emphasizing integrative medicine that incorporates mind-body practices to bring a holistic and proactive approach to healthcare
NYC Builds Bio+
Launched in 2018, NYC Builds Bio+ connects commercial life science opportunities to New York City’s real estate development community through events, research, reports and educational programs. View website
Conducted strategic assessment for the Global Biological Standards Institute followed by development and partial implementation of a 5-year strategic plan. Received financial commitment of $2.5m. View website
Partnered with Biodesign Challenge to launch the first biological competition that engaged art and design students in envisioning future applications of biology. Designs showcased at the Biodesign Summit held at MOMA in NYC. View website
Sustainability Initiative for Synberc, a consortium of UC Berkeley, UC San Francisco, Stanford, Harvard, MIT, and Industry partners, funded by National Science Foundation. Project co-funded by Alfred P. Sloan Foundation and Synberc
- Harvard Law School, J.D., June 1988
- John F. Kennedy School of Government, M.P.P., June 1988.
Areas of Concentration: Business/Government Relations.
Kennedy Fellow, 1984, Dively Fellow, 1985, 1987.
- Yale University, B.A. Economics, magna cum laude, 1984.
Graduation Banner Bearer. Saybrook College, 1984.
- Manchester Community College, A.S. Accounting, 1982.
Valedictorian; 1982 Truman Scholar from CT; 1989 Distinguished Alumni Award;
Featured Alumni in 2001 Statewide Ad Campaign; Commencement Speaker, May 2014.
- Harvard Business School, May 1997.
Continuing Education: Strategic Perspectives in Non-Profit Management.